Proceedings of the 2nd Global Health and Innovation in conjunction with 6th ORL Head and Neck Oncology Conference (ORLHN 2021)

<Previous Article In Volume
Next Article In Volume>

Extranodal Natural Killer (NK)/T-cell Lymphoma Nasal type

A Case Report

Authors
Selvianti Selvianti
Abdul Wahab Sjahranie Samarinda General Hospital, Indonesia
Corresponding author. Email: selviantidr@yahoo.co.id
Corresponding Author
Selvianti Selvianti
Available Online 21 February 2022.
DOI
10.2991/ahsr.k.220206.043How to use a DOI?
Keywords
Non-Hodgkin Lymphoma; ENKTCL-NT; chemotherapy; radiotherapy
Abstract

Extranodal Natural Killer (NK) / T-cell Lymphoma, Nasal type (ENKTCL-NT) is a rare type of Non-Hodgkin Lymphoma (NHL), commonly involves midline areas of the nasal cavity, oral cavity, and/or pharynx. ENKTCL-NT has a very strong relationship with Epstein Barr virus (EBV) infection. Treatment of ENKTCL-NT consists of chemotherapy combined with radiotherapy. This report describes a case of ENKTCL-NT in 55 years old female manifesting as unilateral swelling and mass of right nasal cavity. Treatment plans include a chemotherapy regimen with CHOP (cyclophosphamide, doxorubicin, vincristine dan prednisone) and radiotherapy.

Copyright
© 2022 The Authors. Published by Atlantis Press International B.V.
Open Access
This is an open access article under the CC BY-NC license.

Download article (PDF)

<Previous Article In Volume
Next Article In Volume>
Volume Title
Proceedings of the 2nd Global Health and Innovation in conjunction with 6th ORL Head and Neck Oncology Conference (ORLHN 2021)
Series
Advances in Health Sciences Research
Publication Date
21 February 2022
ISBN
978-94-6239-540-4
ISSN
2468-5739
DOI
10.2991/ahsr.k.220206.043How to use a DOI?
Copyright
© 2022 The Authors. Published by Atlantis Press International B.V.
Open Access
This is an open access article under the CC BY-NC license.

Cite this article

risenwbib
TY  - CONF
AU  - Selvianti Selvianti
PY  - 2022
DA  - 2022/02/21
TI  - Extranodal Natural Killer (NK)/T-cell Lymphoma Nasal type
BT  - Proceedings of the 2nd Global Health and Innovation in conjunction with 6th ORL Head and Neck Oncology Conference (ORLHN 2021)
PB  - Atlantis Press
SP  - 227
EP  - 230
SN  - 2468-5739
UR  - https://doi.org/10.2991/ahsr.k.220206.043
DO  - 10.2991/ahsr.k.220206.043
ID  - Selvianti2022
ER  -